Chile vs Türkiye: Communicable diseases — Communicable disease incidence
Communicable diseases — Communicable disease incidence over time
- Chile
- Türkiye
How they compare
Chile currently reports 1,483 Cases against 132 Cases in Türkiye, a difference of 1,351 Cases.
That makes Chile's figure about 11.2 times Türkiye's.
Across all 41 years both countries report, Chile has been ahead every year.
Chile ranks 6th and Türkiye ranks 3rd of 34 countries.
Chile has averaged higher in every one of the 5 decades both report.
Head to head by decade
| Decade | Chile | Türkiye | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 52.33 Cases | 5 Cases | 47.33 Cases | Chile |
| 1990s | 407.4 Cases | 28.8 Cases | 378.6 Cases | Chile |
| 2000s | 568.7 Cases | 45.5 Cases | 523.2 Cases | Chile |
| 2010s | 1,072 Cases | 101.5 Cases | 970.5 Cases | Chile |
| 2020s | 1,712 Cases | 84.4 Cases | 1,628 Cases | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher communicable diseases — communicable disease incidence, Chile or Türkiye?
- Chile, at 1,483 Cases against 132 Cases in Türkiye as of 2025.
- What is the difference in communicable diseases — communicable disease incidence between Chile and Türkiye?
- 1,351 Cases, with Chile ahead.
- How many years of comparable data are there for Chile and Türkiye?
- 41 years are reported by both, from 1984 to 2024.
- How do Chile and Türkiye rank globally for communicable diseases — communicable disease incidence?
- Chile ranks 6th and Türkiye ranks 3rd of 34 countries.
- Where does this data come from?
- Organisation for Economic Co-operation and Development, published as Communicable diseases — Communicable disease incidence. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
This dataset presents time series on Acquired Immunodeficiency Syndrome (AIDS), for the number of AIDS cases and incidence rates per 100 000 population at year of diagnosis. It also includes data on incidence of pertussis, measles, and hepatitis B, in terms of rates of reported cases per 100 000 population. Please refer to the Sources and Methods for detailed country-specific information.